Dose Escalation Study of Cyclophosphamide in HIV-Infected Subjects on HAART Receiving SB-728-T
Clinical trial NCT01543152 · COMPLETED
Trial details
- NCT number
- NCT01543152
- Sponsor
- Sangamo Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-12-01
- Primary completion
- 2017-07-07
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.